Haasner Dirk 4
4 · Ovid Therapeutics Inc. · Filed Jan 23, 2018
Insider Transaction Report
Form 4
Haasner Dirk
SVP, Global Regulatory Affairs
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-01-19+30,000→ 30,000 totalExercise: $9.18Exp: 2028-01-18→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date.